The Morin group works towards developing proteomic methods for protein function research and the global analysis of post-translational modifications (e.g., phospho, ubiquitin, methyl, acetyl) with expertise is in advanced proteomics methods, biochemistry and RNA processing. The research focuses on understanding the function of somatically mutated cancer genes, with an emphasis on proteins involved in the regulation of alternative splicing. Dr. Morin’s group also develops proteomic methods for ultra high proteome coverage and quantification of fresh-frozen paraffin-embedded (FFPE) tumour sections.
We are located at Canada's Michael Smith Genome Sciences Centre, part of the BC Cancer Research Centre.
675 West 10th Avenue
Vancouver, British Columbia